Published in Z Gesamte Inn Med on May 01, 1983
A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus. Cell (1985) 16.46
Epidemiology of transmission of cytomegalovirus from mother to preterm infant by breastfeeding. Lancet (2001) 3.36
Predominant immediate-early transcripts of human cytomegalovirus AD 169. J Virol (1984) 3.15
Fibroblasts, epithelial cells, endothelial cells and smooth muscle cells are major targets of human cytomegalovirus infection in lung and gastrointestinal tissues. J Gen Virol (1995) 2.66
Modification of human cytomegalovirus tropism through propagation in vitro is associated with changes in the viral genome. J Gen Virol (1999) 2.33
Human cytomegalovirus infections in nonimmunosuppressed critically ill patients. Crit Care Med (2001) 2.27
The two major structural phosphoproteins (pp65 and pp150) of human cytomegalovirus and their antigenic properties. J Gen Virol (1987) 2.13
Map position and nucleotide sequence of the gene for the large structural phosphoprotein of human cytomegalovirus. J Virol (1987) 2.11
The dominant phosphoprotein pp65 (UL83) of human cytomegalovirus is dispensable for growth in cell culture. J Virol (1995) 2.07
Cardiac uptake of [123I]MIBG separates Parkinson's disease from multiple system atrophy. Neurology (1999) 1.98
Markers of foamy virus infections in monkeys, apes, and accidentally infected humans: appropriate testing fails to confirm suspected foamy virus prevalence in humans. AIDS Res Hum Retroviruses (1995) 1.92
Cytomegalovirus cell tropism. Curr Top Microbiol Immunol (2008) 1.89
Analysis of proteins encoded by IE regions 1 and 2 of human cytomegalovirus using monoclonal antibodies generated against recombinant antigens. Virology (1993) 1.83
Cell types involved in replication and distribution of human cytomegalovirus. Adv Virus Res (1996) 1.72
Human cytomegalovirus cell tropism and pathogenesis. Intervirology (1996) 1.71
Genomic localization, sequence analysis, and transcription of the putative human cytomegalovirus DNA polymerase gene. J Virol (1987) 1.67
The lower matrix protein pp65 is the principal viral antigen present in peripheral blood leukocytes during an active cytomegalovirus infection. J Gen Virol (1992) 1.67
Molecular nature of two Haemophilus influenzae R factors containing resistances and the multiple integration of drug resistance transposons. J Bacteriol (1979) 1.66
Monocyte-derived dendritic cells are permissive to the complete replicative cycle of human cytomegalovirus. J Gen Virol (2000) 1.60
Cytomegalovirus monitoring by polymerase chain reaction of whole blood samples from patients undergoing autologous bone marrow or peripheral blood progenitor cell transplantation. J Infect Dis (1997) 1.57
Identification of the major capsid protein gene of human cytomegalovirus. J Virol (1989) 1.56
Tropism of human cytomegalovirus for endothelial cells is determined by a post-entry step dependent on efficient translocation to the nucleus. J Gen Virol (2000) 1.55
Prokaryotic expression of immunogenic polypeptides of the large phosphoprotein (pp150) of human cytomegalovirus. J Gen Virol (1988) 1.40
Improved automated leucocyte counting and differential in newborns achieved by the haematology analyser CELL-DYN 3500. Clin Lab Haematol (1995) 1.40
Molecular characterization of a small Haemophilus influenzae plasmid specifying beta-lactamase and its relationship to R factors from Neisseria gonorrhoeae. J Gen Microbiol (1979) 1.38
Transmission of cytomegalovirus to preterm infants through breast milk. Pediatr Infect Dis J (1998) 1.35
Structure of the transforming region of human cytomegalovirus AD169. J Virol (1984) 1.35
Tissue macrophages are infected by human cytomegalovirus in vivo. J Infect Dis (1996) 1.35
Continuous clearance of HIV in a vertically infected child. Lancet (1989) 1.35
2-(fluorine-18)fluoro-2-deoxy-D-glucose positron emission tomography in the detection and staging of malignant lymphoma. A bicenter trial. Cancer (2001) 1.30
Drug-resistant human cytomegalovirus infection in children after allogeneic stem cell transplantation may have different clinical outcomes. Blood (2000) 1.30
Early serodiagnosis of acute human cytomegalovirus infection by enzyme-linked immunosorbent assay using recombinant antigens. J Clin Microbiol (1994) 1.29
Risk factors for treatment failures in patients receiving PCR-based preemptive therapy for CMV infection. Bone Marrow Transplant (2000) 1.26
Large-scale screening of human sera with cytomegalovirus recombinant antigens. J Clin Microbiol (1990) 1.25
Monoclonal antibody E-13 (M-810) to human cytomegalovirus recognizes an epitope encoded by exon 2 of the major immediate early gene. J Gen Virol (1992) 1.23
Sequence determination of the 3' end of mouse mammary tumor virus RNA. Mol Biol Rep (1981) 1.21
Human cytomegalovirus as a direct pathogen: correlation of multiorgan involvement and cell distribution with clinical and pathological findings in a case of congenital inclusion disease. J Med Virol (2002) 1.20
Molecular properties of transmissible R factors of Haemophilus influenzae determing tetracycline resistance. J Gen Microbiol (1978) 1.19
Evaluation of plasmids in tetracycline resistant strains of Neisseria gonorrhoeae and Ureaplasma urealyticum in a case of severe urethritis. Eur J Epidemiol (1985) 1.18
Detection of cytomegalovirus antibodies by an enzyme-linked immunosorbent assay using recombinant polypeptides of the large phosphorylated tegument protein pp150. J Clin Microbiol (1992) 1.18
Efficient lytic infection of human arterial endothelial cells by human cytomegalovirus strains. J Virol (2000) 1.17
Cell types infected in human cytomegalovirus placentitis identified by immunohistochemical double staining. Virchows Arch A Pathol Anat Histopathol (1993) 1.17
Cleavage of procaryotically expressed human immunodeficiency virus fusion proteins by factor Xa and application in western blot (immunoblot) assays. J Clin Microbiol (1989) 1.17
Abundant 5 kb RNA of human cytomegalovirus without a major translational reading frame. J Gen Virol (1988) 1.13
Cytomegalovirus infection of extremely low-birth weight infants via breast milk. Clin Infect Dis (2001) 1.13
The DNA-binding protein pUL57 of human cytomegalovirus is a major target antigen for the immunoglobulin M antibody response during acute infection. J Clin Microbiol (1995) 1.12
Staging of pelvic lymph nodes in neoplasms of the bladder and prostate by positron emission tomography with 2-[(18)F]-2-deoxy-D-glucose. Eur Urol (1999) 1.09
Comprehensive restriction analysis of the UL97 region allows early detection of ganciclovir-resistant human cytomegalovirus in an immunocompromised child. J Infect Dis (1999) 1.05
Quantification of replication of clinical cytomegalovirus isolates in cultured endothelial cells and fibroblasts by a focus expansion assay. J Virol Methods (1997) 1.04
Multiplicity dependent expression of the predominant phosphoprotein pp65 of human cytomegalovirus. Virus Res (1989) 1.03
Generation and effective enrichment of selectable human cytomegalovirus mutants using site-directed insertion of the neo gene. Gene (1993) 1.02
Origin of Haemophilus influenzae R factors. J Bacteriol (1981) 1.02
Detection of cytomegaloviral DNA in human milk cells and cell free milk whey by nested PCR. J Virol Methods (1998) 1.02
[13C]octanoic acid breath test for non-invasive assessment of gastric emptying in diabetic patients: validation and relationship to gastric symptoms and cardiovascular autonomic function. Diabetologia (1996) 1.01
Cytomegalovirus antigenemia assay: identification of the viral antigen as the lower matrix protein pp65. J Infect Dis (1992) 1.01
A simple and rapid method for preparation of viral DNA from cell associated cytomegalovirus. J Virol Methods (1999) 0.99
A simplified assay for screening of drug resistance of cell-associated cytomegalovirus strains. J Clin Virol (1998) 0.98
Discordant detection of human cytomegalovirus DNA from peripheral blood mononuclear cells, granulocytes and plasma: correlation to viremia and HCMV infection. J Clin Virol (1998) 0.98
Human cytomegalovirus: recent aspects from molecular biology. J Gen Virol (1989) 0.98
Human trophoblast cells are permissive to the complete replicative cycle of human cytomegalovirus. J Virol (1998) 0.96
FDG-PET imaging for the staging and follow-up of small cell lung cancer. Eur J Nucl Med (2001) 0.94
[Positron emission tomography with [18 F]-2-fluoro-2-deoxy-D-glucose (18FDG-PET) in diagnosis of retroperitoneal lymph node metastases of testicular tumors]. Urologe A (1998) 0.94
RPR 119990, a novel alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid antagonist: synthesis, pharmacological properties, and activity in an animal model of amyotrophic lateral sclerosis. J Pharmacol Exp Ther (2001) 0.94
Evaluation of Murex CMV DNA hybrid capture assay for detection and quantitation of cytomegalovirus infection in patients following allogeneic stem cell transplantation. J Clin Microbiol (1998) 0.93
Management of cytomegalovirus infection after solid-organ or stem-cell transplantation. Current guidelines and future prospects. Drugs (1998) 0.93
In vitro comparison of the antigen-binding and stability properties of the various molecular forms of IgA antibodies assembled and produced in CHO cells. Proc Natl Acad Sci U S A (1999) 0.93
Absence of foamy virus DNA in Graves' disease. AIDS Res Hum Retroviruses (1994) 0.91
Detection of varicella zoster virus DNA and viral antigen in human cornea after herpes zoster ophthalmicus. Cornea (1993) 0.91
Screening for CMV-specific T cell proliferation to identify patients at risk of developing late onset CMV disease. Bone Marrow Transplant (1997) 0.91
Cerebral perfusion during transient global amnesia: findings with HMPAO SPECT. J Nucl Med (1998) 0.90
Studies on the quality of breast milk during 23 months of lactation in a rural community of the Ivory Coast. Am J Clin Nutr (1979) 0.90
Procaryotic expression of phosphorylated tegument protein pp65 of human cytomegalovirus and application of recombinant peptides for immunoblot analyses. J Clin Microbiol (1990) 0.90
Wideband harmonic imaging: a novel contrast ultrasound imaging technique. Eur Radiol (1999) 0.90
[Chlamydia trachomatis infection in a patient with condylomata acuminata]. Geburtshilfe Frauenheilkd (1986) 0.89
Viral culture and p24 antigenemia of human immunodeficiency virus (HIV)-infected individuals correlated with antibody profiles determined with recombinant polypeptides of all HIV-1 open-reading frames. J Infect Dis (1992) 0.89
Transcriptional analysis of the eight-kilobase mRNA encoding the major capsid protein of human cytomegalovirus. J Virol (1990) 0.89
Monitoring of CMV infection: a comparison of PCR from whole blood, plasma-PCR, pp65-antigenemia and virus culture in patients after bone marrow transplantation. Bone Marrow Transplant (1996) 0.89
Impaired cardiac uptake of meta-[123I]iodobenzylguanidine in Parkinson's disease with autonomic failure. Acta Neurol Scand (1998) 0.88
Induction of CMV-specific T-cell lines using Ag-presenting cells pulsed with CMV protein or peptide. Cytotherapy (2002) 0.88
Freeze-thawing of breast milk does not prevent cytomegalovirus transmission to a preterm infant. Arch Dis Child Fetal Neonatal Ed (2006) 0.88
Rapid development of ganciclovir-resistant cytomegalovirus infection in children after allogeneic stem cell transplantation in the early phase of immune cell recovery. Bone Marrow Transplant (2002) 0.88
Interleukin-1-like activity constitutively generated by Hodgkin derived cell lines. I. Measurement in a human lymphocyte co-stimulator assay. Immunobiology (1984) 0.87
Prokaryotic expression of the major capsid protein of human cytomegalovirus and antigenic cross-reactions with herpes simplex virus type 1. J Gen Virol (1990) 0.86
Detection of human cytomegalovirus DNA and viral antigens in tissues of different manifestations of CMV infection. Virchows Arch B Cell Pathol Incl Mol Pathol (1988) 0.86
AAV for pain: steps towards clinical translation. Gene Ther (2009) 0.86
Cleavage and purification of prokaryotically expressed HIV gag and env fusion proteins for detection of HIV antibodies in the ELISA. Virology (1991) 0.85
Herpesvirus saimiri transformed human T cell lines: a permissive system for human immunodeficiency viruses. Virology (1993) 0.85
Immunohistochemical detection of viral antigens in smooth muscle, stromal, and epithelial cells from acute human cytomegalovirus gastritis. J Infect Dis (1993) 0.85
Inhibition of HIV-1 replication by a high-copy-number vector expressing antisense RNA for reverse transcriptase. Gene (1993) 0.85
IgM-specific serodiagnosis of acute human cytomegalovirus infection using recombinant autologous fusion proteins. J Virol Methods (1996) 0.84
Modulation of blood pressure and the renin-angiotensin system in transgenic and spontaneously hypertensive rats afer ovariectomy. J Hypertens Suppl (1993) 0.84
CMV infection after allogeneic bone marrow transplantation is associated with the occurrence of various autoantibodies and monoclonal gammopathies. Br J Haematol (1996) 0.84
Acoustic behaviour of current ultrasound contrast agents. Ultrasonics (2000) 0.84
Polarized transport of the polymeric immunoglobulin receptor in transfected rabbit mammary epithelial cells. J Cell Biol (1990) 0.84
Cephalosporin-induced cholestatic jaundice. Lancet (1982) 0.84
Apparently non-specific results found using a norovirus antigen immunoassay for fecal specimens from neonates. J Perinatol (2008) 0.84
Hepatocytes are permissive for human cytomegalovirus infection in human liver cell culture and In vivo. J Infect Dis (1999) 0.83
Triple retinal infection with human immunodeficiency virus type 1, cytomegalovirus, and herpes simplex virus type 1. Light and electron microscopy, immunohistochemistry, and in situ hybridization. Ophthalmology (1994) 0.83